Nationwide Recall of ADHD Medication Due to Ineffective Dosage
Gray News | October 28, 2025 – A nationwide recall has been issued for Lisdexamfetamine Dimesylate Capsules, a common form of Vyvanse, after the product failed to meet essential dissolution standards. The U.S. Food and Drug Administration (FDA) announced the recall on October 28, 2025, stating that the issue could cause the medication to deliver … Read more